These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19856430)

  • 21. Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.
    Jørgensen E; Helqvist S; Kløvgaard L; Kastrup J; Clemmensen P; Holmvang L; Engstrøm T; Saunamaki K; Kelbaek H
    Scand Cardiovasc J; 2009 Apr; 43(2):87-93. PubMed ID: 19031301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement.
    Mehrle A; Skelton T; Almonacid A
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):988-91. PubMed ID: 17191207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous late stent thrombosis of drug-eluting stents causing acute anterior and inferior myocardial infarction.
    Arora N; Aggarwal K
    J Invasive Cardiol; 2008 Jan; 20(1):E14-7. PubMed ID: 18174623
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary stent fracture: the hidden truth of a problem more common than stent thrombosis.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):88-9. PubMed ID: 19089948
    [No Abstract]   [Full Text] [Related]  

  • 25. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 26. Treating the left main bifurcation lesion: the "three stent solution".
    Uretsky BF
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):42-3. PubMed ID: 19089935
    [No Abstract]   [Full Text] [Related]  

  • 27. We can build it, but will they come?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2011 May; 77(6):818-9. PubMed ID: 21520383
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
    Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
    JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
    De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
    Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we really understand pimecrolimus?
    Vorpahl M; Finn AV; Nakano M; Virmani R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1025-7. PubMed ID: 19850265
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical extraction of occluded stents: when stenting becomes a problem.
    Atoui R; Mohammadi S; Shum-Tim D
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):736-8. PubMed ID: 19640865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unprotected left main intervention: the light at the end of the tunnel?
    Stone GW; Mintz GS
    Circ Cardiovasc Interv; 2009 Jun; 2(3):156-8. PubMed ID: 20031711
    [No Abstract]   [Full Text] [Related]  

  • 34. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. If you want to stent ... do intravascular ultrasound!
    Hodgson JM
    JACC Cardiovasc Interv; 2010 Aug; 3(8):818-20. PubMed ID: 20723853
    [No Abstract]   [Full Text] [Related]  

  • 36. The artisan approach for stenting bifurcation lesions.
    Colombo A; Latib A
    JACC Cardiovasc Interv; 2010 Jan; 3(1):66-7. PubMed ID: 20129571
    [No Abstract]   [Full Text] [Related]  

  • 37. Seal to prevent spreading: it makes sense!
    Colombo A
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):441-2. PubMed ID: 12652490
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple stent fractures at the site of coronary artery bypass insertion.
    Hetterich H; Rieber J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):84-7. PubMed ID: 19089946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should the left main be covered entirely with drug-eluting stents in percutaneous intervention.
    Lozano I; Avanzas P; Moris C
    J Invasive Cardiol; 2006 Nov; 18(11):E276-8. PubMed ID: 17090829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.